Recalls / Class II
Class IID-0538-2022
Product
HPC Tablet (Acetaminophen 110 mg, Aspirin 162 mg, Caffeine 32.4 mg, Salicylamide 152 mg) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62969-242-00
- Affected lot / code info
- Product Codes: L242SRC Bulk Lot: 18K086, 18L009, 18L050, 18L083, 18M025, 18M073, 18M098, 19A010, 19A084, 19A105, 19A107; Product Code: L242L Bulk Lot: 19H014; Product Code: L242PA Bulk Lot: 18F072, 18L119, 19A067, 19G043; Product Code: L242N Bulk Lot: 19H040
Why it was recalled
CGMP Deviations
Recalling firm
- Firm
- ULTRAtab Laboratories, Inc.
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 50 Toc Dr, N/A, Highland, New York 12528-1506
Distribution
- Quantity
- 50,585,623 tablets
- Distribution pattern
- Bulk product was distributed to 3 distributors who may have distributed finished product.
Timeline
- Recall initiated
- 2022-01-26
- FDA classified
- 2022-02-09
- Posted by FDA
- 2022-02-16
- Terminated
- 2025-01-07
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0538-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.